Core Insights - Millicom has successfully acquired Telefónica's telecommunications operations in Ecuador for USD 380 million, enhancing its presence in South America [1][2] - This acquisition is part of Millicom's strategy to deepen its footprint in high-potential markets, following its recent acquisition in Uruguay [2][3] - The CEO of Millicom emphasized the company's long-term confidence in Latin America and its commitment to digital connectivity and sustainable growth [3] Company Overview - Millicom operates in eleven countries and is recognized as a leading telecommunications group in Latin America, focusing on digital inclusion and innovation [3] - The company provides a variety of digital services, including mobile financial services, local entertainment, pay TV, and business solutions, serving over 46 million customers [8] Ecuador Market Profile - Ecuador has a population of approximately 18.1 million, with a youthful demographic and a significant urban population, creating a connected consumer base [7] - The economy is dollarized with solid macroeconomic fundamentals, projected GDP growth of 1.7% in 2025 and 2.0% in 2026, and low inflation around 1.3% [7] - The telecommunications market in Ecuador is competitive, with steady demand for mobile and broadband services, showing growth rates of approximately +1.4% in mobile and +3.6% in fixed broadband [7]

Business Highlights Third quarter of 2025 sales increased 22% Q/Q and increased 14% Y/Y SSD controller sales: 3Q of 2025 increased 20% to 25% Q/Q and decreased 0% to 5% Y/YeMMC+UFS controller sales: 3Q of 2025 increased 20% to 25% Q/Q and increased 35% to 40% Y/YSSD solutions sales: 3Q of 2025 increased 15% to 20% Q/Q and decreased 40% to 45% Y/Y Financial Highlights 3Q 2025 GAAP3Q 2025 Non-GAAP*• Net sales$242.0 million (+22% Q/Q, +14% Y/Y)$242.0 million (+22% Q/Q, +14% Y/Y)• Gross margin<td style="max-w ...

LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), an institutional commodity tokenization company, today announced that it has received formal approval from Nasdaq for continued listing of its shares of common stock on the Nasdaq Capital Market under the ticker symbol “STEX.” In conjunction with the Nasdaq approval, Streamex will convene a special meeting of shareholders at 3:00 PM EST on November 4, 2025, to reconvene the previously adjourned Propos ...

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced two poster presentations featuring BBO-10203, a first-in-class, orally bioavailable, selective breaker of the RAS:PI3Kα interaction, at the San Antonio Breast Cancer Symposium (SABCS) being held December 9-12, 2025, in San Antonio, Texas. The abstracts released today can be found on the SA ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended September 30, 2025. Business Update Discretionary assets under management (“AUM”), which primarily drives the firm’s top-line revenue, increased $687 million during the third quarter, primarily due to beneficial equity markets. Silvercrest added $46.4 million in organic new client accounts during the third quart ...

DALLAS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that, by letter dated October 29, 2025, the Company was notified by The Nasdaq Stock Market, LLC (“Nasdaq”) that the Company had regained compliance with (i) the Nasdaq periodic reporting requiremen ...

Core Insights - Gran Tierra Energy Inc. reported financial and operational results for Q3 2025, highlighting continued operational success and exploration achievements in Ecuador and Colombia [1][2][4] Production and Operations - Total average working interest production was 42,685 barrels of oil equivalent per day (boepd), a 30% increase compared to Q3 2024 [10] - Current production is approximately 45,200 boepd, with an expected exit rate of 47,000 to 50,000 boepd [4][14] - Production was temporarily impacted by a landslide in Ecuador and trunk line repairs at the Moqueta field, leading to deferred production rather than lost production [4][12] Exploration Success - In Ecuador, the Conejo A-1 and A-2 wells achieved significant exploration success, with Conejo A-1 producing at stabilized rates of 1,328 barrels of oil per day (bopd) [7][11] - The Chanangue-1 well re-entered and tested previously bypassed formations, currently producing approximately 600 bopd [11] - In Colombia, the Cohembi field reached production levels not seen in over a decade, with output increasing by approximately 135% [3][11] Financial Performance - Gran Tierra incurred a net loss of $20 million in Q3 2025, compared to a net loss of $13 million in the prior quarter [14][16] - Adjusted EBITDA was $69 million, down from $77 million in the prior quarter [14][16] - Capital expenditures were $57 million during the quarter, primarily focused on exploration drilling and infrastructure [14][16] Capital Structure and Liquidity - The company secured a $200 million prepayment facility and increased its Canadian credit facility from C$50 million to C$75 million [6][9] - As of September 30, 2025, Gran Tierra had a cash balance of $49 million and total debt of $804 million [14][16] Operational Metrics - Operating netback was $18.89 per boe, down 12% from the prior quarter, primarily due to increased operating expenses [14][15] - Gross profit decreased 70% to $14.7 million compared to $48.8 million in Q3 2024 [14][16] - Total operating expenses increased by 22% to $68 million, attributed to higher workover activities and lifting costs [14][16]

MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™ is an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years of age.1 “Effective ADHD management begins with helping children transition smoot ...

Core Insights - Koss Corporation reported a significant increase in net sales and a turnaround in net income for the first quarter ended September 30, 2025, with net sales reaching $4,070,778, a 27.1% increase from $3,201,868 in the same period last year, and net income of $243,729 compared to a net loss of $419,535 in the prior year [2][3]. Financial Performance - Net sales for the quarter were $4,070,778, up by $868,910 or 27.1% from the previous year [2]. - The company achieved a net income of $243,729, contrasting with a net loss of $419,535 in the first quarter of the prior fiscal year [2]. - Basic and diluted net income per share were both $0.03, compared to a loss of $0.05 per share in the same quarter last year [2]. Sales Growth Drivers - A significant sale to the largest Education market customer and a 22.5% growth in direct-to-consumer (DTC) sales contributed to the sales success [3]. - Sales to European markets declined year-over-year, primarily due to distributors delaying re-orders, while Asian market sales remained strong [3]. - DTC sales benefited from new product launches and new colorways introduced in the previous fiscal year [3]. Margin Improvement - Gross margins improved by 340 basis points, increasing from 36.6% to 40.0% compared to the same period last year, driven by a favorable customer and market mix [3]. - The company faced challenges with gross margins due to high tariffs on China-produced goods but managed to offset some impacts through better absorption of fixed manufacturing costs and reduced reserves for excess inventory [4]. Leadership Changes - Michael J. Koss, Jr. was promoted to Executive Vice President, recognizing his contributions to product development and growth in the DTC segment [5].

Core Points - Nyxoah will release its financial results for the third quarter of 2025 on November 13, 2025, followed by a conference call to discuss these results [1][2][3] Company Overview - Nyxoah is a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA) through neuromodulation [4] - The company's lead product is the Genio system, which is a leadless and battery-free hypoglossal neurostimulation therapy for OSA, a condition linked to increased mortality risk and cardiovascular issues [4] Recent Developments - The Genio system received its European CE Mark in 2019 after the successful completion of the BLAST OSA study [5] - Nyxoah has completed two IPOs, one on Euronext Brussels in September 2020 and another on NASDAQ in July 2021 [5] - Following positive outcomes from the BETTER SLEEP study, the company expanded its therapeutic indications to include Complete Concentric Collapse (CCC) patients, which are currently contraindicated in competitors' therapies [5] - The company also announced positive results from the DREAM IDE pivotal study and received U.S. FDA approval for a Premarket Approval application in August 2025 [5]